Organon & annual revenue
2019
2020
2021
2022
2023
2024
2025
Organon & Revenue Growth & History (OGN)
Organon & reported $6.22B in revenue for fiscal 2025, a decrease of 2.92% from the previous fiscal year.
View full Organon & company overviewOrganon & annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.22B | −$187.0M | −2.92% |
| 2024 | 2024-12-31 | $6.40B | $140.0M | +2.24% |
| 2023 | 2023-12-31 | $6.26B | $89.0M | +1.44% |
| 2022 | 2022-12-31 | $6.17B | −$130.0M | −2.06% |
| 2021 | 2021-12-31 | $6.30B | −$228.0M | −3.49% |
| 2020 | 2020-12-31 | $6.53B | −$1.25B | −16.01% |
| 2019 | 2019-12-31 | $7.78B | — | — |
Organon & quarterly revenue
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.56B | −$36.0M | −2.26% |
| Q1 2026 | 2026-03-31 | $1.46B | −$53.0M | −3.50% |
| Q4 2025 | 2025-12-31 | $1.51B | −$85.0M | −5.34% |
| Q3 2025 | 2025-09-30 | $1.60B | $20.0M | +1.26% |
| Q2 2025 | 2025-06-30 | $1.59B | −$13.0M | −0.81% |
| Q1 2025 | 2025-03-31 | $1.51B | −$109.0M | −6.72% |
| Q4 2024 | 2024-12-31 | $1.59B | −$6.0M | −0.38% |
| Q3 2024 | 2024-09-30 | $1.58B | $63.0M | +4.15% |
| Q2 2024 | 2024-06-30 | $1.61B | −$1.0M | −0.06% |
| Q1 2024 | 2024-03-31 | $1.62B | $84.0M | +5.46% |
| Q4 2023 | 2023-12-31 | $1.60B | $113.0M | +7.61% |
| Q3 2023 | 2023-09-30 | $1.52B | −$18.0M | −1.17% |
| Q2 2023 | 2023-06-30 | $1.61B | $23.0M | +1.45% |
| Q1 2023 | 2023-03-31 | $1.54B | −$29.0M | −1.85% |
| Q4 2022 | 2022-12-31 | $1.49B | — | — |
| Q3 2022 | 2022-09-30 | $1.54B | −$63.0M | −3.94% |
| Q2 2022 | 2022-06-30 | $1.58B | −$10.0M | −0.63% |
| Q1 2022 | 2022-03-31 | $1.57B | $61.0M | +4.05% |
| Q3 2021 | 2021-09-30 | $1.60B | −$13.0M | −0.81% |
| Q2 2021 · Jun 30 | 2021-06-30 | $1.59B | $69.0M | +4.52% |
| Q1 2021 | 2021-03-31 | $1.51B | −$274.0M | −15.39% |
| Q4 2020 | 2020-12-31 | $1.61B | — | — |
| Q3 2020 | 2020-09-30 | $1.61B | — | — |
| Q2 2020 | 2020-06-30 | $1.53B | — | — |
| Q1 2020 | 2020-03-31 | $1.78B | — | — |
Organon & revenue growth trends
Over the last five reported fiscal years, revenue declined from $6.53B to $6.22B, a compound annual decline of 0.99%. Organon &'s latest reported quarter, Q2 2026, generated $1.56B in revenue, a decrease of 2.26% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Organon & source filings ↗